Haidari, Tamim Ahmad
Bjerrum, Flemming
Christensen, Thomas Decker
Vad, Henrik
Møller, Lars Borgbjerg
Hansen, Henrik Jessen
Konge, Lars
Petersen, René Horsleben
Article History
Received: 8 November 2021
Accepted: 2 April 2022
First Online: 25 April 2022
Declarations
:
: FB, LK, HV and LBM have no conflicts of interests to disclose. RHP: Speaker fee Medtronic, AMBU, AstraZeneca and Advisory Board: AstraZeneca, Roche and MSD. HJH: Speaker fee Medtronic, Medela and BD/Bard. TDC has been on the speaker bureaus for AstraZeneca, Boehringer-Ingelheim, Pfizer, Roche Diagnostics, Takeda, Merck Sharp & Dohme (MSD) and Bristol-Myers Squibb and has been in an Advisory Board for Bayer and Merck Sharp & Dohme (MSD).